Ampetic Pharma Private Limited
About Ampetic Pharma Private Limited
Data last updated:
Ampetic Pharma Private Limited is a private limited company based in Muzaffarpur, Bihar, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 24 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2017PTC034111. Its GSTIN is 10AAPCA3702R1ZK (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ridhima Kumari and Smita.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Muzaffarpur, Bihar.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.1 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹1,918 (net margin 0.3%) and EBITDA of ₹2,359 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 180% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O – Chandra Kishore Singh Saraiyaganj Muzaffapur 1 Brahmsthan Cho, Wk, Muzaffarpur, Bihar, India – 842001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ampetic Pharma Private Limited
The main business activity of Ampetic Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ampetic Pharma Private Limited FY 2022 filings available
Ampetic Pharma Private Limited reported revenue of ₹6.1 Lakh (up 28% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Ampetic Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 180% over three years, including 28% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ampetic Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2,359 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,918 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ampetic Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ampetic Pharma are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ampetic Pharma Private Limited
Ampetic Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biozorix Lifesciences Private Limited | ₹6.13 Lakh (FY 2021) | •••• | •••• | •••• | Patna, Bihar, India | |
| Makore Laboratories Private Limited | ₹6.13 Lakh (FY 2017) | •••• | •••• | -80.0% | •••• | Hyderabad, Telangana, India |
| Alstone Silicones Private Limited | ₹6.12 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | New Delhi, Delhi, India |
| Sreetech Pharma (India) Private Limited | ₹6.12 Lakh (FY 2023) | •••• | •••• | -43.0% | •••• | Hyderabad, Telangana, India |
| Curasion Remedies Private Limited | ₹6.11 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Makaraba, Ahmedabad, Gujarat, India |
| Ampetic Pharma Private Limited this company | ₹6.1 Lakh (FY 2022) | •••• | •••• | 28.0% | •••• | Muzaffarpur, Bihar, India |
| Xcute Pharmaceutical Private Limited | ₹6.1 Lakh (FY 2024) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Mahasulph (India) Private Limited | ₹6.09 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Pune, Maharashtra, India |
| Medilexicon Pharmaceuticals Private Limited | ₹6.09 Lakh (FY 2024) | •••• | •••• | 23.0% | •••• | Jaipur, Rajasthan, India |
| Morsus Remedies Private Limited | ₹6.09 Lakh (FY 2018) | •••• | •••• | 538.0% | •••• | Lucknow, Uttar Pradesh, India |
| Nobel Enkem Private Limited | ₹6.08 Lakh (FY 2024) | •••• | •••• | 3.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Ampetic Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Ampetic Pharma Private Limited
Ampetic Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ridhima Kumari | Director | 07 Nov 2019 | 6 Years 11 Months | Current |
| Smita | Director | 07 Nov 2019 | 6 Years 11 Months | Current |
Ownership and Shareholding of Ampetic Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ampetic Pharma Private Limited
Ampetic Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ampetic Pharma Private Limited
Employment history and EPFO contributions of people linked to Ampetic Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ampetic Pharma Private Limited
Ampetic Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Alok Kumar ceased to be Director on 07 Nov 2019.
Credit Ratings, Litigation & Regulatory Alerts for Ampetic Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ampetic Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ampetic Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ampetic Pharma Private Limited
Ampetic Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAPCA3702R1ZK | Bihar | Active | 10 Feb 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ampetic Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ampetic Pharma Private Limited
Ampetic Pharma is an active private limited company based in Muzaffarpur, Bihar, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 24 March 2017 (9+ years old) and is registered under CIN U74999BR2017PTC034111.
Ampetic Pharma reported revenue of ₹6.1 Lakh for FY 2022 (up 28% YoY).
Ampetic Pharma has 2 current directors:
- Ridhima Kumari - Director
- Smita - Director
Ampetic Pharma reported a net profit of ₹1,918 (net margin 0.3%) and EBITDA of ₹2,359 (EBITDA margin 0.4%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ampetic Pharma is 180% over three years. In the latest year (FY 2022) revenue rose 28%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ampetic Pharma is 10AAPCA3702R1ZK, registered in Bihar.
The CIN (Corporate Identification Number) of Ampetic Pharma is U74999BR2017PTC034111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ampetic Pharma was incorporated on 24 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Ampetic Pharma by revenue are Biozorix Lifesciences Private Limited, Makore Laboratories Private Limited, Alstone Silicones Private Limited, Sreetech Pharma (India) Private Limited, Curasion Remedies Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Alok Kumar ceased to be Director on 07 Nov 2019. Kishan ceased to be Director on 07 Nov 2019. Ridhima Kumari was appointed as Director on 07 Nov 2019. Ampetic Pharma has 4 board changes on record in total.
The registered office of Ampetic Pharma is at CO – Chandra Kishore Singh Saraiyaganj Muzaffapur 1 Brahmsthan Cho, Wk, Muzaffarpur, Bihar, India – 842001.